{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:20:24Z","timestamp":1785788424693,"version":"3.56.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":249,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1111\/ced.12540","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T06:57:49Z","timestamp":1419577069000},"page":"383-386","source":"Crossref","is-referenced-by-count":41,"title":["Acne conglobata and adalimumab: use of tumour necrosis factor-\u03b1 antagonists in treatment-resistant acne conglobata, and review of the literature"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-074X","authenticated-orcid":false,"given":"Z. Z. N.","family":"Yiu","sequence":"first","affiliation":[{"name":"Dermatology Centre; Salford Royal NHS Foundation Trust; Manchester Academic Health Science Centre; University of Manchester; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Madan","sequence":"additional","affiliation":[{"name":"Dermatology Centre; Salford Royal NHS Foundation Trust; Manchester Academic Health Science Centre; University of Manchester; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E. M.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Dermatology Centre; Salford Royal NHS Foundation Trust; Manchester Academic Health Science Centre; University of Manchester; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,26]]},"reference":[{"key":"10.1111\/ced.12540-BIB0001|ced12540-cit-0001","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamadermatol.2013.6678","article-title":"Adalimumab for the treatment of refractory acne conglobata","volume":"149","author":"Sand","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/ced.12540-BIB0002|ced12540-cit-0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/11593250-000000000-00000","article-title":"Long-term treatment of severe SAPHO syndrome with adalimumab","volume":"13","author":"Garcovich","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/ced.12540-BIB0003|ced12540-cit-0003","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1111\/ced.12540-BIB0004|ced12540-cit-0004","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archdermatol.2010.16","article-title":"3 cases of dissecting cellulitis of the scalp treated with adalimumab: control of inflammation within residual structural disease","volume":"146","author":"Navarini","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/ced.12540-BIB0005|ced12540-cit-0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2133.2004.05762.x","article-title":"Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P.\u00a0acnes GroEL","volume":"150","author":"Graham","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/ced.12540-BIB0006|ced12540-cit-0006","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2009.09420.x","article-title":"Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris","volume":"162","author":"Caillon","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/ced.12540-BIB0007|ced12540-cit-0007","doi-asserted-by":"crossref","DOI":"10.1111\/ijd.12416","article-title":"Acneiform eruption as a probable paradoxical reaction to adalimumab","author":"Fernandez-Crehuet","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1111\/ced.12540-BIB0008|ced12540-cit-0008","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrgastro.2012.125","article-title":"Paradoxical inflammation induced by anti-TNF agents in patients with IBD","volume":"9","author":"Cleynen","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1111\/ced.12540-BIB0009|ced12540-cit-0009","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2340\/00015555-0046","article-title":"Severe acne successfully treated with etanercept","volume":"86","author":"Campione","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/ced.12540-BIB0010|ced12540-cit-0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfma.2013.10.001","article-title":"SAPHO syndrome associated with acne conglobata successfully treated with etanercept","author":"Su","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/ced.12540-BIB0011|ced12540-cit-0011","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jaad.2005.06.008","article-title":"Treatment of acne conglobata with infliximab","volume":"55","author":"Shirakawa","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12540-BIB0012|ced12540-cit-0012","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2230.2010.03998.x","article-title":"Sustained remission of nodular inflammatory acne after treatment with infliximab","volume":"36","author":"Schuttelaar","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/ced.12540-BIB0013|ced12540-cit-0013","first-page":"444","article-title":"Biologics for rare inflammatory diseases: TNF blockade in the SAPHO syndrome","volume":"70","author":"Burgemeister","year":"2012","journal-title":"Neth J Med"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12540","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.12540\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:40:35Z","timestamp":1676367635000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/40\/4\/383\/6621161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,26]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12540","relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,26]]}}}